Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.66B P/E - EPS this Y -9.00% Ern Qtrly Grth -
Income -478M Forward P/E 3.78 EPS next Y 16.70% 50D Avg Chg 19.00%
Sales 16B PEG 4.37 EPS past 5Y -0.30% 200D Avg Chg 4.00%
Dividend N/A Price/Book 1.32 EPS next 5Y 1.60% 52W High Chg -19.00%
Recommedations 2.40 Quick Ratio 0.47 Shares Outstanding 1.13B 52W Low Chg 30.00%
Insider Own - ROA 4.84% Shares Float 1.13B Beta 1.05
Inst Own 52.14% ROE -9.67% Shares Shorted/Prior 11.66M/11.56M Price 9.25
Gross Margin 48.96% Profit Margin -2.99% Avg. Volume 14,211,503 Target Price 17.25
Oper. Margin 17.28% Earnings Date Jul 31 Volume 32,973,594 Change 11.58%
About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Teva Pharmaceutical Industries News
05/17/24 Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
05/15/24 Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
05/14/24 Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
05/14/24 Israel’s Once-Dominant Drugmaker Is Revived by Innovation
05/13/24 Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
05/09/24 TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
05/09/24 Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
05/09/24 Affirm stock sinking, Good Buy or Goodbye: Market Domination
05/09/24 Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
05/09/24 Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
05/08/24 Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
05/08/24 Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
05/08/24 Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
05/08/24 Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
05/08/24 REFILE-UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue rises
05/08/24 Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
05/08/24 Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
05/08/24 Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
05/07/24 20 States with the Highest Fertility Rates in the US
05/06/24 Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
TEVA Chatroom

User Image DocDriz Posted - 1 day ago

$TEVA Exited all May 17 2024 $14 calls over the last few trading days for ~350% gain. Looking for the next opportunity to load some short term options while my Jan 25 $10s keep me company.

User Image Gemineye Posted - 1 day ago

$TEVA I just voted and let me tell you I was against the whole board! Also you only get to “negotiate” your pay every three years not every year! Gees I should have been a CEO they do nothing and make HUGE💰💰😳

User Image LakersandVRX Posted - 1 day ago

$TEVA Ending the day green is definitely a positive sign. Hopefully all the S-T speculators have left, and we start heading back up next week. I'll be happy when this hits the mid 20s. I will then assess the stock again.

User Image Crandaddy01 Posted - 2 days ago

$TEVA well that was fun!

User Image aetherialcereal Posted - 2 days ago

I was wroooong $TEVA

User Image Gemineye Posted - 2 days ago

$TEVA I’m sorry I ever met you! 7 painful years I endured shit now pay up MF’s! I’ve been abused way too long

User Image marine8888 Posted - 2 days ago

$TEVA I hope this goes to the moon soon. I’ve been holding long and it needs to be my retirement someday. All cards on the table and it’s in God’s hands now.

User Image Gemineye Posted - 2 days ago

$TEVA https://www.europeanpharmaceuticalreview.com/news/229070/new-evp-teva-global-operations-appointed/

User Image Gemineye Posted - 2 days ago

$TEVA https://news.bloomberglaw.com/health-law-and-business/teva-investors-dodge-appeal-of-class-status-in-ms-drug-lawsuit

User Image TheDudeRooster Posted - 2 days ago

$TEVA Right at the bottom of the channel. Let's see if my lucky arrow works lol.

User Image Sdotrayborn Posted - 2 days ago

$TEVA no way people crying right ? 😂😂

User Image ICEGIRL Posted - 2 days ago

$TEVA Cup and handle. 😊

User Image tony96 Posted - 2 days ago

$TEVA consolidating just relax it’s very healthy long as it holds 16 we’re good

User Image Terrordomo80 Posted - 2 days ago

$TEVA

User Image TheDudeRooster Posted - 2 days ago

$TEVA Okay, that’s enough of that 😂

User Image VegasG Posted - 2 days ago

$TEVA Not liking the new EVP?

User Image Terrordomo80 Posted - 2 days ago

$TEVA last 2 days feel like the inverse post earnings call... that slope looks awfully slippery...

User Image LakersandVRX Posted - 3 days ago

$TEVA When it comes to investing, it's not about being right all the time. Although, I wouldn't mind having that ability...but then, I would be the richest man on the planet, have hundreds of millions of followers, and hire Elon to shut up. In reality, it's about being right more than being wrong. If I can be right 52% and wrong 48....I will be happy.

User Image Gemineye Posted - 3 days ago

$TEVA and the bitch of it is only when Big $$ comes in will it move

User Image Terrordomo80 Posted - 3 days ago

$TEVA And here I was under the impression ye ol TEVA would go straight to the moon without ever pulling back again... now comes the question of how far will we pull back now that they suckered in a ton of new money @ 5 year highs... best of luck TEVAdians!!!

User Image Gemineye Posted - 3 days ago

$TEVA

User Image TheDudeRooster Posted - 3 days ago

$TEVA Looking like a pump action day after that red candle

User Image TeresaTrades Posted - 3 days ago

Largest CALL OI decreases $TEVA $GME $COIN $DUK $CYX

User Image NNJAWINLIVE Posted - 3 days ago

$TEVA 20 plus long-term going higher

User Image TheDudeRooster Posted - 3 days ago

$TEVA Man, I hope they are resetting the channel. Check out the flawless resistance.

User Image TheDudeRooster Posted - 3 days ago

$TEVA I’ve never been so happy to see a red candle being bullish. We needed that 👍

User Image aetherialcereal Posted - 3 days ago

$TEVA This is going over $17 EOW

User Image TheRipple Posted - 3 days ago

$TEVA 👀👁️

User Image LakersandVRX Posted - 4 days ago

$TEVA At least we all know when an idiot joins the board. JB needs to go study instead of wasting his time here. Hanging out in tents will only get his parents angry bc it will lead to bad grades.

User Image Longaeva_Capital Posted - 4 days ago

$TEVA yassssssss

Analyst Ratings
Piper Sandler Overweight May 13, 24
Barclays Overweight May 9, 24
JP Morgan Neutral Mar 8, 24
Piper Sandler Overweight Feb 12, 24
Goldman Sachs Neutral Feb 5, 24
Barclays Overweight Feb 5, 24
Barclays Overweight Jan 29, 24
Jefferies Buy Jan 23, 24
Piper Sandler Neutral Jan 3, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Weiss Amir Chief Accounting Off.. Chief Accounting Officer Feb 01 Sell 12.3703 31,766 392,955 10,676 02/05/24
Hughes Eric A See "Remarks" See "Remarks" Aug 01 Sell 8.3 52,742 437,759 08/03/23
Kalif Eliyahu Sharon EVP, Chief Financial.. EVP, Chief Financial Officer Aug 22 Sell 10.0666 55,500 558,696 9,376 08/24/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Jul 28 Sell 9.0365 58,163 525,590 2,974 07/29/22
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D May 17 Sell 8.2159 130,000 1,068,067 1,387 05/19/22
Drape Eric Executive VP Global.. Executive VP Global Operations Mar 04 Sell 7.44 34,792 258,852 78,072 03/08/22
Dethlefs Sven EVP, North America C.. EVP, North America Commercial Mar 04 Sell 7.42 10,897 80,856 165,381 03/08/22
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Mar 04 Sell 7.44 58,952 438,603 43,182 03/08/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Feb 28 Sell 8.14 6,452 52,519 21,380 03/02/22
Shani Eli EVP,Global Marketing.. EVP,Global Marketing&Portfolio Feb 28 Sell 8.14 5,311 43,232 9,091 03/02/22
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D Feb 28 Sell 8.14 7,590 61,783 65,509 03/02/22
Drape Eric Executive VP Global.. Executive VP Global Operations Feb 28 Sell 8.14 9,797 79,748 45,830 03/02/22
Dethlefs Sven EVP, North America C.. EVP, North America Commercial Feb 28 Sell 8.14 4,862 39,577 99,457 03/02/22
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Feb 28 Sell 8.14 20,598 167,668 20,280 03/02/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Feb 08 Sell 9.06 6,110 55,357 9,402 02/10/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer May 13 Sell 10.22 37,884 387,174 2,974 05/13/21
Drape Eric Executive VP Global.. Executive VP Global Operations May 13 Sell 10.22 19,804 202,397 73,128 05/13/21
Nazzi Gianfranco EVP, International M.. EVP, International Markets Mar 08 Sell 10.58 12,935 136,852 03/08/21
Drape Eric Executive VP Global.. Executive VP Global Operations Mar 08 Sell 10.58 6,183 65,416 55,048 03/08/21
Dethlefs Sven EVP Global Marketing.. EVP Global Marketing&Portfolio Mar 08 Sell 10.57 6,012 63,547 77,976 03/08/21
Nazzi Gianfranco EVP, International M.. EVP, International Markets Mar 04 Sell 10.88 1,400 15,232 03/04/21
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D Feb 17 Sell 11.12 2,098 23,330 103,294 02/17/21
O'Grady Brendan P. EVP, North America C.. EVP, North America Commercial Feb 11 Sell 12.69 20,694 262,607 78,146 02/11/21
Dethlefs Sven EVP Global Marketing.. EVP Global Marketing&Portfolio Feb 11 Sell 12.69 29,657 376,347 59,404 02/11/21
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Sep 10 Sell 8.98 333 2,990 10,765 09/10/20